Clinical Trial: A Phase I Clinical Study to evaluate the safety, tolerability and pharmacokinetics of Rupatifen Fumarate Capsules in Healthy Subjects (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase I Clinical Study to evaluate the safety, tolerability and pharmacokinetics of Rupatifen Fumarate Capsules in Healthy Subjects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132459

Registration Time: 2026/09/14

Type: Interventional study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334016

Published by HT Digital Content Services with permission from Health Daily Digest....